DiaSys signs distribution partnership in Mexico:
This article was originally published in Clinica
DiaSys has signed a deal with Mexican diagnostic products distributor Grupo Mex Lab that will enable the Waterbury, Connecticut firm to sell its parasite sets to private and public labs in Mexico. It said the reimbursed value of the market for these tests is about $140m. Some 28 million parasite tests are performed annually in Mexico, the large majority of them by state bodies. The company has also signed up Chile's largest diagnostics distributor, Galencia, to sell its products throughout the country.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.